Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an Abbreviated New Drug Application; Guidance for Industry; Availability
FDA-2013-D-1464-0022Notice
Document
Details
The document's own metadata, straight from the source system.
- Title
- Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an Abbreviated New Drug Application; Guidance for Industry; Availability
- Posted
- May 29, 2026